Clinical Trials Directory

Trials / Completed

CompletedNCT03501420

Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP)

Patient Phenotypes and Treatment Pathways in Primary Sjogren's Syndrome: an International Cross-sectional Survey of Rheumatologists and Adult Primary Sjögren's Syndrome Patients With Systemic Involvement (Adelphi 2018 pSS Disease Specific Programme)

Status
Completed
Phase
Study type
Observational
Enrollment
2,223 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

Sjogren's Syndrome is a chronic autoimmune disease characterized by sicca (dryness) symptoms of the mouth and eyes. This autoimmune disease is less commonly studied and there are no licensed treatments to treat the underlying cause of disease and current management is based on clinical experience and/or small clinical studies. This study is based on DSP methodology, a multinational, cross-sectional, multi-sponsor survey of robust real-world data. DSP methodology collects quantitative market research data. The pSS DSP will survey a sample of approximately 230 to 325 rheumatologists and their prospectively consulting pSS subjects in France, Germany, Italy, Spain and the US. The data will be collected via physician interviews, physician workload questionnaires, detailed patient record forms (PRFs) to be completed by physicians, and a self-completion questionnaire by pSS subjects. The data collected using this method includes subjective and objective evidence, clinical information about individual patients, their disease and their treatment. This DSP will follow three key phases: preparatory phase, data collection phase and data processing/analysis phase.

Conditions

Interventions

TypeNameDescription
OTHERInterviewA one hour survey interview will be completed by the rheumatologists which will contain open and closed questions to probe physician perception and behaviors in relation to pSS management and treatment
OTHERPSC questionnaireAll subjects for whom the physician completes a PRF will be required to complete a PSC questionnaire independently of their physician, immediately after consultation.
OTHERPRFsPRFs will be completed by the physicians for seven of their consulting pSS subjects.

Timeline

Start date
2018-06-13
Primary completion
2018-10-30
Completion
2018-10-30
First posted
2018-04-18
Last updated
2019-01-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03501420. Inclusion in this directory is not an endorsement.